Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.080
+0.050 (1.65%)
At close: Mar 28, 2025, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Mar 28, 2025, 6:14 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $114.87 million as of March 28, 2025. Its market cap has decreased by -33.24% in one year.
Market Cap
114.87M
Enterprise Value
85.84M
1-Year Change
-33.24%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $114.87M, a decrease of -18.93%. That is a compound annual growth rate of -9.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 114.87M | 42.72% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |